Article

Huma's innovative approach to tackling medication adherence

May 23, 2023
Article

Huma's innovative approach to tackling medication adherence

May 23, 2023

Arrash Yassaee

Global Clinical Director

This is some text inside of a div block.
mins read
Speaker shot.

Speaker shot.

Speaker shot.

The impact of non-adherence on patient health

Compliance with therapies is a crucial factor in determining the success of treatment. Non-adherence poses a significant problem that not only impacts the patient but also the healthcare system. The failure to adhere to medication regimens by patients can result in a considerable deterioration of the underlying condition, unnecessary hospital admissions, leading to higher mortality rates and an increase in healthcare expenditure.

According to published studies, including those by the WHO, estimates are that adherence to chronic medications is only around 50%.1 Observational studies have seen an average rate of 4.29% of hospital admissions associated with non-adherence. 2 

A variety of factors are likely to affect adherence. Patient education and empowerment,  inconsistent symptoms, and complicated drug treatment regimes are all factors. For disease areas such as oncology, (where the dosing burden can be particularly high), there are also logistical challenges which require clear communication between patient, provider and health system, to ensure regimes are followed accurately and to completion. 

In a study concerning atrial fibrillation, the Huma platform was shown to achieve up to 99% adherence with key study data points.

Sarraju, A., Seninger, C., Parameswaran, V. et al.

How Huma’s new medication module helps encourage medication adherence.

In Huma’s latest product release (released in May 2023), our product and engineering team have focused on this key challenge - how can we make adhering to prescribed medications easier for patients and clinicians, and improve health outcomes?  

Based on our first-hand experience through hundreds of deployments, and observing patient interactions, our new medication module has been completely re-imagined, to focus on solving this key challenge.

Now both clinicians and patients can efficiently enter medications directly into the Huma platform, either via the mobile app (for patients) or the clinician dashboard. In the UK, integration with Snomed, a medication terminology database, makes finding and entering the prescribed medication easier and faster. Specific medication regimes can be entered into the platform precisely, with options for medication name, dosage (for example take one capsule every four hours, or 500 mg daily), maximum dosage, frequency and time of day.  Medications to be taken ‘as and when needed’ can also be logged by the patient.

For patients and clinicians involved with complex drug regimes, the new Huma medications module offers the flexibility to cater to a wide variety of medication scenarios. For example, an Asthma patient, advised to take two preventer inhalations daily, plus a reliever inhalation as and when required, can log both types of treatment in the medications module. An oncology patient, who might need to take a combination of 3-4 different drug therapies, all at different dosage and frequency, can set up individual medications.

Once their medication schedule is set up (by either a clinician or the patient themselves), reminder notifications are pushed out to the patient, informing them of when their medication is due, and prompting them to update their medications log.

On the clinician portal, any new medications added or deleted by the patient are added to the clinician view of patient medications. If patients exceed a dose, based on the previously defined maximum dosage, a red flag is raised to the clinician. Additionally, a monthly overview enables clinicians to quickly overview a patient's adherence history.

This field is required
Email must be formatted correctly
This field is required
This field is required
This field is required

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

As well as the medication module, Huma has also integrated a learn module into its patient side application. Here, healthcare providers can publish supporting articles, guides and videos to help educate patients on their disease area, treatment and medications, further encouraging adherence.  

In clinical trials, the Huma remote patient monitoring platform has already proven to be effective in encouraging adherence. In a study concerning atrial fibrillation, the Huma platform was shown to achieve up to 99% adherence with key study data points 3. Now with this latest enhancement to our platform, Huma continues to focus on helping to solve one of healthcare’s most intractable challenges, and in doing so, improve overall health outcomes.

This field is required
This field is required
This field is required
This field is required
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form

Contact us to discover more

Email must be formatted correctly
This field is required
This field is required
This field is required
This field is required
This field is required
Country/Region*
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

You’re in control. You can, of course, withdraw your consent at any time. Review our Privacy Policy for further information.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Making an impact

3000+

3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1

×2

Our platform can almost double clinical capacity and reduce readmission rates by >30%3

27m+

Huma's digital-first health platforms support a network of 27m patients1

1m+

Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Sources:

  1. Medication adherence: WHO cares? https://pubmed.ncbi.nlm.nih.gov/21389250/ 
  2. Hospital admissions associated with medication non-adherence: a systematic review of prospective observational studies https://pubmed.ncbi.nlm.nih.gov/29666309/
  3. Sarraju, A., Seninger, C., Parameswaran, V. et al. Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP). npj Digit. Med. 5, 80 (2022). https://doi.org/10.1038/s41746-022-00622-9)
Article

Huma's innovative approach to tackling medication adherence

May 23, 2023
Article

Huma's innovative approach to tackling medication adherence

May 23, 2023

Huma joins digital pioneers to advance health equity in care and research

Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.

Huma joins digital pioneers to advance health equity in care and research

Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.

Huma is one of the first to sign the Zero Health Gaps Pledge

Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.

Huma at World Economic Forum

Global Innovators and Tech Pioneers
Dec 2022: Huma selected to join 100 innovative companies on a two-year journey as part of the World Economic Forum’s initiatives, activities and events, bringing their cutting-edge insight and fresh thinking to critical global discussions.
Learn more
Working Together, Restoring Trust
May 2022: With the aim to address economic, environmental, political, and social fault-lines exacerbated by the COVID-19 pandemic, Dan Vahdat speaks at WEF annual meeting about the importance of scientific collaboration.
Learn more
Accelerating innovation and breaking new ground
October 2022: Dan joined the WEF Biotech Future Forum 2022 to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
Learn more
Making connections at Davos
Jan 2019: Dan attended WEF as an unofficial attendee and spoke to CNBC about the importance of meeting in-person to make connections.
Learn more

Related Articles

See more
Article
AI is in our DNA
Explore how Huma has been developing AI to revolutionise healthcare, and request a meeting with us to find out more.
Learn more
Article
“It’s really gold dust” Why Huma is a big step forward for knee surgery
Discover how Huma is providing Smith+Nephew with real world evidence for robotic knee replacement surgery.
Learn more

Related Blogs

See more
Blog
Feeling depressed linked to short-term increase in bodyweight, study finds
Learn more
Blog
How Huma is transforming Health
Tim Broke-Smith, Huma's Vice President, Global Pharma Partnerships, considers how cutting edge technology can transform healthcare.
Learn more

Related Ebooks

See more
Ebook
Welcome to next-generation digital-first care and research
Deliver more personalised digital-first care and research with the first disease agnostic enterprise platform to achieve EU MDR Class IIb certification1.
Learn more
Ebook
What does FDA 510(k) Class II mean for Huma and our partners
Deliver more personalised digital-first care and research with our enterprise platform which now has FDA 510 (K) Class II clearance for any physician-specified condition.
Learn more

Related White Papers

See more
White Paper
Navigating the DCT transition
Learn how remote trial technology is changing the clinical trial landscape and key considerations when including DCT components in your study protocols.
Learn more
Article

Huma's innovative approach to tackling medication adherence

May 23, 2023
Media contact
A headshot of Karen Birmingham PhD
Karen Birmingham PhD
Head of PR & Communications
karen.birmingham@huma.com
Article

Huma's innovative approach to tackling medication adherence

May 23, 2023
Media contact
A headshot of Karen Birmingham PhD
Karen Birmingham PhD
Head of PR & Communications
karen.birmingham@huma.com

The impact of non-adherence on patient health

Compliance with therapies is a crucial factor in determining the success of treatment. Non-adherence poses a significant problem that not only impacts the patient but also the healthcare system. The failure to adhere to medication regimens by patients can result in a considerable deterioration of the underlying condition, unnecessary hospital admissions, leading to higher mortality rates and an increase in healthcare expenditure.

According to published studies, including those by the WHO, estimates are that adherence to chronic medications is only around 50%.1 Observational studies have seen an average rate of 4.29% of hospital admissions associated with non-adherence. 2 

A variety of factors are likely to affect adherence. Patient education and empowerment,  inconsistent symptoms, and complicated drug treatment regimes are all factors. For disease areas such as oncology, (where the dosing burden can be particularly high), there are also logistical challenges which require clear communication between patient, provider and health system, to ensure regimes are followed accurately and to completion. 

asdasd

asda

asdsads

asda

asdsad

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Share this
COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more